Sonoma Pharmaceuticals, Inc. financial data

Symbol
SNOA on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5445 Conestoga Court, Suite 150, Boulder, CO
State of incorporation
DE
Fiscal year end
March 31
Former names
Oculus Innovative Sciences, Inc. (to 12/2/2016)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355 % +5.77%
Quick Ratio 80.6 % +9.94%
Debt-to-equity 145 % +15.4%
Return On Equity -63.7 % +31.5%
Return On Assets -26 % +36.9%
Operating Margin -31.6 % +29.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.34M shares -90.2%
Common Stock, Shares, Outstanding 1.34M shares -74.2%
Entity Public Float 3.8M USD -99.9%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.03M shares +301%
Weighted Average Number of Shares Outstanding, Diluted 1.03M shares +301%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13.5M USD +11.8%
Revenue from Contract with Customer, Excluding Assessed Tax 13.5M USD +11.8%
Research and Development Expense 1.99M USD +200%
Operating Income (Loss) -4.28M USD +21.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.74M USD +38.6%
Income Tax Expense (Benefit) -56K USD -202%
Net Income (Loss) Attributable to Parent -3.69M USD +40.1%
Earnings Per Share, Basic 4.85 USD/shares +89.7%
Earnings Per Share, Diluted 4.85 USD/shares +89.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.08M USD +90.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.16M USD +42%
Inventory, Net 2.84M USD +12.9%
Assets, Current 12.2M USD +6.12%
Deferred Income Tax Assets, Net 792K USD -5.71%
Property, Plant and Equipment, Net 255K USD -41.1%
Operating Lease, Right-of-Use Asset 162K USD -53.7%
Other Assets, Noncurrent 76K USD +1.33%
Assets 13.7M USD +0.37%
Accounts Payable, Current 770K USD -22%
Employee-related Liabilities, Current 1.42M USD -3.01%
Liabilities, Current 3.31M USD +2.16%
Operating Lease, Liability, Noncurrent 46K USD -65.7%
Liabilities 8.33M USD +4.69%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.2M USD -34.5%
Retained Earnings (Accumulated Deficit) -196M USD -1.92%
Stockholders' Equity Attributable to Parent 5.35M USD -5.69%
Liabilities and Equity 13.7M USD +0.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -912K USD -324%
Net Cash Provided by (Used in) Financing Activities 636K USD
Net Cash Provided by (Used in) Investing Activities -5K USD +70.6%
Common Stock, Shares Authorized 50M shares +108%
Common Stock, Shares, Issued 1.34M shares -74.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -539K USD -95.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.08M USD +90.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD 0%
Deferred Tax Assets, Valuation Allowance 30.8M USD +0.09%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 32.1M USD +0.62%
Operating Lease, Liability 162K USD -53.7%
Payments to Acquire Property, Plant, and Equipment 5K USD -70.6%
Lessee, Operating Lease, Liability, to be Paid 177K USD -54.7%
Property, Plant and Equipment, Gross 2.75M USD +9.71%
Operating Lease, Liability, Current 116K USD -46.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD -91.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 67K USD -53.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 90K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15K USD -63.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 28.7M USD +0.47%
Unrecognized Tax Benefits 20K USD -63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15K USD -85.4%
Depreciation, Depletion and Amortization 39K USD -13.3%
Deferred Tax Assets, Net of Valuation Allowance 1.3M USD +15.2%